(2e)-3-{4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl}prop-2-enoic acid, 98%, 250mg

(3-Methyl-isoxazol-5-yl)-acetonitrile, 95.0%, 250mg

2-Ethynylpyridin-3-amine, 97%, 100mg

7-Oxo-7-(4-isopropoxyphenyl)heptanoic acid, 97.0%, 1g

1-(TERT-BUTOXYCARBONYLAMINO)-4,4-DIFLUOROCYCLOHEXANECARBOXYLIC ACID, 95.0%, 500mg

3-[(prop-2-ynylamino)sulfonyl]benzoic acid, 100mg

2-(2-chloroethyl)-1-methyl-1H-imidazole hydrochloride, 95.0%, 1g

4-(N-Methylaminocarbonyl)phenylboronic acid, 95.0%, 10g

METHYL 4-AMINO-2,5-DIFLUOROBENZOATE, 95.0%, 5g

bScope BS.1153-PLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

3-Chloro-5-methylpyrazine-2-carbonitrile, 95%, 250mg

Methyl (2S,4S)-4-hydroxypyrrolidine-2-carboxylate hydrochloride, 95.0%, 50g

5-(Bromomethyl)pyridine-2-carbonitrile, 95.0%, 250mg